In vitro leishmanicidal, antibacterial and antitumour potential of anhydrocochlioquinone A obtained from the fungus Cochliobolus sp.
The bioassay-guided fractionation of the ethyl acetate extract of the fungus Cochliobolus sp. highlighted leishmanicidalactivity and allowed for anhydrocochlioquinone A (ANDC-A) isolation. MS, 1D and 2D NMR spectra of this compoundwere in agreement with those published in the literature. ANDC-A exhibited leishmanicidal activity with EC50 value of22.4 lg/mL (44 lM) and, when submitted to the microdilution assay against Gram-positive and Gram-negative bacteria,showed a minimal inhibitory concentration against Staphylococcus aureus ATCC 25295 of 128 lg/mL (248.7 lM). It wasalso active against five human cancer cell lines, showing IC50 values from 5.4 to 20.3 lM. ANDC-A demonstrated adifferential selectivity for HL-60 (SI 5.5) and THP-1 (SI 4.3) cell lines in comparison with Vero cells and was moreselective than cisplatin and doxorubicin against MCF-7 cell line in comparison with human peripheral blood mononuclearcells. ANDC-A was able to eradicate clonogenic tumour cells at concentrations of 20 and 50 lM and induced apoptosis inall tumour cell lines at 20 lM. These results suggest that ANDC-A might be used as a biochemical tool in the study oftumour cells biochemistry as well as an anticancer agent with durable effects on tumours.
Volume 45, 2020
Continuous Article Publishing mode
Click here for Editorial Note on CAP Mode